Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
4
80%
Ph phase_2
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(3)

Detailed Status

Completed3
Enrolling by invitation1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (20.0%)
N/A4 (80.0%)

Trials by Status

completed360%
enrolling_by_invitation120%
active_not_recruiting120%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
DEVICE
Total Trials
5